MARINA BIOTECH
Our mission is to provide effective and patient centric treatment for hypertension- including resistant hypertension. In doing so creating a universal platform for the effective treatment of hypertension as well as for the distribution of fixed dose combination [FDC] hypertensive drugs such as Prestalia® and those in our pipeline. The company commercial product Prestalia® is approved by US FDA for the treatment of hypertension and being commercialized through the DyrctAxess platform. The com... pany is also developing and commercializing late stage, non-addictive pain therapeutics. The company’s ‘next-generation of celecoxib,’ including IT-102 and IT-103, are designed to control the dangerous side-effect of edema that prohibits the drug from being prescribed at higher doses. These have the potential of replacing opioids and combatting the opioid epidemic.
MARINA BIOTECH
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1983-01-01
Address:
City Of Industry, California, United States
Country:
United States
Website Url:
http://www.marinabio.com
Total Employee:
11+
Status:
Closed
Contact:
626-964-5788
Email Addresses:
[email protected]
Total Funding:
19.9 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Advanced Pain Care
Physicians & Surgeon Pain Management
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
GCR
Pattient Intelligence for the new generation
GeneLook
Patient Responsive DNA-sharing Platform
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-07-24 | DyrctAxess | DyrctAxess acquired by Marina Biotech | N/A |
| 2010-07-28 | Novosom | Novosom acquired by Marina Biotech | N/A |
| 2010-04-01 | Cequent Pharmaceuticals | Cequent Pharmaceuticals acquired by Marina Biotech | 46 M USD |
Investors List
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Post-IPO Equity - Marina Biotech
Steven T. Newby
Steven T. Newby investment in Post-IPO Equity - Marina Biotech
Official Site Inspections
http://www.marinabio.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
